AIS causes massive death worldwide and only two treatments are approved by the FDA to date (1): mechanical removal of thrombus via endovascular thrombectomy, and (2) pharmacological thrombolysis by using t-PA that promotes degradation of fibrin in thrombus by activating endogenous plasminogen (146). Here, PLAT is linked to androgen insensitivity syndrome.